Abiomed, Inc.: FDA Approves RECOVER IV Randomized Controlled

FDA Also Approves and Closes RECOVER III Post-Approval Study Abiomed (Nasdaq: ABMD) announces two approvals from the U.S. Food and Drug Administration (FDA) related to clinical research of Impella

Related Keywords

Germany , New York , United States , Italy , Japan , Massachusetts , Tufts Medical Center , Jenny Leary , Todd Trapp , William Oneill , Navink Kapur , Mount Sinai Heart Health System , Us Communications , Drug Administration , Exchange Commission , Abiomed , European Society Of Cardiology , Structural Heart Disease At Henry Ford Health , Cardiovascular Center , Business Wire , Williamo Neill , Structural Heart Disease , Henry Ford Health , Kansas City Cardiomyopathy Questionnaire , Shock Clinical , European Society , Cardiac Arrest , Informed Consent , Institutional Review Board , United Statesa , Vice President , Chief Financial Officer , Pproves , Ecover , Randomized , Ontrolled , Trial , Exception , Rom , Nformed , Consent , Fific ,